Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 861177 NEW YORK, NY
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,316,223
-$194,813 QoQ
Shares Held
90,338
+13.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 242 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. SMMT ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in SMMT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,316,223 90,338
2026-03-31 $1,511,036 79,696
2025-12-31 $1,392,658 79,626
2025-09-30 $1,644,308 79,589
2025-06-30 $1,848,997 86,889
2024-03-31 $474,410 114,592
2023-12-31 $150,858 57,800
2023-09-30 $108,086 57,800